There comes a time in Symptomatic heart failure NYHA functional class III or IV, where the patient has no more options to be treated with and death is inevitable. That patient would have the option to be treated with Ixmyelocel-T or continue as is.
Thanks Laser for clarification. I misunderstood, and was thinking there was also a "over the counter", and maybe cheaper, version of ixCell, that I was missing here.
Again, thanks for clarification.
I will not sell a single share of $VCEL below $40.